Category: Myriad

png

Myriad Launches riskScore™ Beginning the Next Epoch in Hereditary Cancer Testing

July 9, 2020
Gene Analysis, Myriad

Provides Individualized Breast Cancer Risk for Patients Testing Negative with the myRisk® Hereditary Cancer Test

Crescendo Bioscience Announces Results

June 9, 2020
General, Myriad, Tests

Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017 Annual European Congress of Rheumatology

Myriad’s BRACAnalysis CDx® Test Identified Patients with Metastatic Breast Cancer Who Benefited from Treatment with Olaparib in Phase 3 OlympiAD Study

June 7, 2020
General, Myriad, Tests

Company to Seek FDA Approval of BRACAnalysis CDx Test in HER2- Metastatic Breast Cancer